Frederic Moll - Sep 17, 2021 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
Director
Signature
/s/ Alaleh Nouri, Attorney-in-Fact for Frederic Moll
Stock symbol
PRCT
Transactions as of
Sep 17, 2021
Transactions value $
$10,000,000
Form type
4
Date filed
9/21/2021, 06:34 PM
Previous filing
Sep 14, 2021
Next filing
Dec 1, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Conversion of derivative security +330K +216.14% 483K Sep 17, 2021 Direct F1
transaction PRCT Common Stock Purchase $10M +400K +82.9% $25.00 883K Sep 17, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRCT Series B Convertible Preferred Stock Conversion of derivative security -45.6K -100% 0 Sep 17, 2021 Common Stock 45.6K $0.00 Direct F1
transaction PRCT Series C Convertible Preferred Stock Conversion of derivative security -89.8K -100% 0 Sep 17, 2021 Common Stock 89.8K $0.00 Direct F1
transaction PRCT Series D Convertible Preferred Stock Conversion of derivative security -108K -100% 0 Sep 17, 2021 Common Stock 108K $0.00 Direct F1
transaction PRCT Series E Convertible Preferred Stock Conversion of derivative security -9.1K -100% 0 Sep 17, 2021 Common Stock 9.1K $0.00 Direct F1
transaction PRCT Series F Convertible Preferred Stock Conversion of derivative security -17K -100% 0 Sep 17, 2021 Common Stock 17K $0.00 Direct F1
transaction PRCT Series G Convertible Preferred Stock Conversion of derivative security -60.2K -100% 0 Sep 17, 2021 Common Stock 60.2K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date.
F2 Represents a purchase in the Issuer's public offering.